to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11.
Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas.
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas.
Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study.
Current therapeutic approaches in patients with brain metastases.
Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma.
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma.
A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme.
Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report.
Neoplasm Recurrence, Local
Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Anaplastic ganglioglioma: a report of three cases and review of the literature.
Impact of temozolomide on gonadal function in patients with primary malignant brain tumors.
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.
Neoplasm Recurrence Local